Small Extracellular Vesicles from Human Amniotic Fluid Samples as Promising Theranostics

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Extracellular Vesicles

Background:

• Mesenchymal stem cells offer therapeutic benefits through paracrine signaling.
• Human amniotic fluid stem cells (hAFSC) are a promising source of regenerative progenitors.
• Extracellular vesicles (EVs) from hAFSC mimic cellular therapeutic effects.

Purpose of the Study:

• To review the potential of EVs derived from hAFSC and amniotic fluid (hAF) for clinical applications.
• To discuss the challenges in the isolation, characterization, and quantification of these EVs for therapeutic use.

Main Methods:

• Review of preclinical studies on hAFSC and hAF-derived EVs.
• Analysis of research on the paracrine mechanisms of hAFSC.
• Examination of methods for EV isolation and characterization.

Main Results:

• hAFSC-EVs demonstrate significant regenerative, anti-inflammatory, and proliferative effects in preclinical models.
• EVs from hAF can potentially provide prenatal diagnostic information.
• hAFSC-EVs show therapeutic promise for both adult and neonatal diseases.

Conclusions:

• hAFSC and their secreted EVs represent a viable source for regenerative therapies.
• Further research is needed to overcome challenges in EV manufacturing for clinical translation.
• EVs hold potential for both therapeutic applications and prenatal diagnostics.